The APAC arthroscopy devices market is expected to grow from US$ 1,070.05 million in 2021 to US$ 1,911.65 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.
Obesity is currently an epidemic known as "globesity," affecting millions across the region. Obesity has a considerable effect on the musculoskeletal system, resulting in the degeneration of bones, cartilage, and ligaments. According to the study published by the WHO, in 2020, the frequency of obesity among the regional population has tripled since 1975. Furthermore, according to the same study, 38 million children below 5 years of age were overweight in 2019. This massive prevalence of obesity is likely to accelerate due to unhealthy habits such as consumption of junk food, sedentary lifestyle, genetic conditions, and deprivation of mental health. Obesity is a major risk factor for OA development and progression. Obesity is associated with OA, a chronic joint condition caused by increased force across the joint and other pro-inflammatory factors such as inflammation throughout the body. Body mass index (BMI) values enhance joint pain symptoms and severity. Furthermore, for every 11 pounds gained the risk of having OA increases by 36%. Compared to leaner individuals, women with obesity have roughly four times the risk of knee OA, while men with obesity have five times the risk. Obesity is linked to an increased chance of developing rheumatoid arthritis (RA). Given the recent rapid rise in the prevalence of obesity, this risk factor appears to have a major impact on the incidence of RA. It may account for a significant percentage of the recent increase in RA among women. Being overweight can exacerbate the symptoms of RA, lead to serious other health issues, and make some arthritis medications less effective. Hence, the increased prevalence of obesity is anticipated to drive the market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC arthroscopy devices market. The APAC arthroscopy devices market is expected to grow at a good CAGR during the forecast period.
The APAC arthroscopy devices market is segmented based on product, application, and country. Based on product, the market is segmented into arthroscopic implants, arthroscopes, fluid management systems, radiofrequency systems, visualization systems, powered shavers systems, and other arthroscopy instruments. The arthroscopes segment dominated the market in 2020, and the same segment is expected to be the fastest-growing segment during the forecast period. Based on application, the market is segmented into knee arthroscopy, hip arthroscopy, spine arthroscopy, foot and ankle arthroscopy, shoulder and elbow arthroscopy, and others. The hip arthroscopy segment dominated the market in 2020, and the same segment is expected to be the fastest-growing segment during the forecast period. Based on country, the APAC arthroscopy devices market has been segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC.
ARL STORZ SE & Co. KG; Arthrex, Inc.; CONMED Corporation; Johnson and Johnson Services, Inc.; Medtronic; NuVasive, Inc.; Richard Wolf GmbH.; Smith & Nephew; Stryker Corporation; and Zimmer Biomet are among the leading companies in the APAC arthroscopy devices market.